Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fetal cells enter maternal blood during pregnancy and persist in women with autoimmune disease. The frequency of subsequent fetomaternal microchimerism in healthy women and its cell type is unknown. To test the hypothesis that fetal mesenchymal stem cells persist in maternal organs, we studied female bone marrow and ribs. Male cells were identified by XY fluorescence in-situ hybridisation in marrow-derived mesenchymal stem cells and in rib sections from all women with male pregnancies, but not in controls (9/9 vs 0/5, p=0.0005). We conclude that fetal stem cells transferred into maternal blood engraft in marrow, where they remain throughout life. This finding has implications for normal pregnancy, for obstetric complications that increase fetomaternal trafficking, and for graft survival after transplantation.

Original publication

DOI

10.1016/S0140-6736(04)16631-2

Type

Journal article

Journal

Lancet

Publication Date

10/07/2004

Volume

364

Pages

179 - 182

Keywords

Aged, Aged, 80 and over, Bone Marrow Cells, Bone and Bones, Chimera, Chromosomes, Human, X, Chromosomes, Human, Y, Female, Fetus, Humans, In Situ Hybridization, Fluorescence, Male, Maternal-Fetal Exchange, Mesoderm, Middle Aged, Pregnancy, Ribs, Stem Cells, Time Factors